Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer

被引:129
作者
Abo-Madyan, Yasser [1 ,2 ]
Aziz, Muhammad Hammad [1 ,3 ]
Aly, Moamen M. O. M. [4 ,5 ]
Schneider, Frank [1 ]
Sperk, Elena [1 ]
Clausen, Sven [1 ]
Giordano, Frank A. [1 ]
Herskind, Carsten [1 ]
Steil, Volker [1 ]
Wenz, Frederik [1 ]
Glatting, Gerhard [1 ,4 ]
机构
[1] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Dept Radiat Oncol, D-68167 Mannheim, Germany
[2] Cairo Univ, Fac Med, Dept Radiat Oncol & Nucl Med NEMROCK, Giza, Egypt
[3] COMSATS Inst Informat & Technol, Dept Phys, Islamabad, Pakistan
[4] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, D-68167 Mannheim, Germany
[5] Assiut Univ, South Egypt Canc Inst, Dept Radiotherapy & Nucl Med, Assiut, Egypt
关键词
Second cancer risk; Organ equivalent dose (OED); Breast cancer; Intensity modulated radiation therapy (IMRT); MODULATED RADIATION-THERAPY; MONTE-CARLO; CONTRALATERAL BREAST; ADJUVANT RADIOTHERAPY; RANDOMIZED-TRIAL; SURVIVORS; EFFICACY;
D O I
10.1016/j.radonc.2013.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Second cancer risk after breast conserving therapy is becoming more important due to improved long term survival rates. In this study, we estimate the risks for developing a solid second cancer after radiotherapy of breast cancer using the concept of organ equivalent dose (OED). Materials and methods: Computer-tomography scans of 10 representative breast cancer patients were selected for this study. Three-dimensional conformal radiotherapy (3D-CRT), tangential intensity modulated radiotherapy (t-IMRT), multibeam intensity modulated radiotherapy (m-IMRT), and volumetric modulated arc therapy (VMAT) were planned to deliver a total dose of 50 Gy in 2 Gy fractions. Differential dose volume histograms (dDVHs) were created and the OEDs calculated. Second cancer risks of ipsilateral, contralateral lung and contralateral breast cancer were estimated using linear, linear-exponential and plateau models for second cancer risk. Results: Compared to 3D-CRT, cumulative excess absolute risks (EAR) for t-IMRT, m-IMRT and VMAT were increased by 2 +/- 15%, 131 +/- 85%, 123 +/- 66% for the linear-exponential risk model, 9 +/- 22%, 82 +/- 96%, 71 +/- 82% for the linear and 3 +/- 14%, 123 +/- 78%, 113 +/- 61% for the plateau model, respectively. Conclusion: Second cancer risk after 3D-CRT or t-IMRT is lower than for m-IMRT or VMAT by about 34% for the linear model and 50% for the linear-exponential and plateau models, respectively. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 31 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
Abo-Madyan Y, 2008, STRAHLENTHER ONKOL, V184, P86, DOI [10.1007/s00066-008-1730-9, 10.1007/S00066-008-1730-9]
[3]   Contralateral breast dose from chest wall and breast irradiation: local experience [J].
Alzoubi, A. S. ;
Kandaiya, S. ;
Shukri, A. ;
Elsherbieny, E. .
AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2010, 33 (02) :137-144
[4]   Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays? [J].
Aziz, Muhammad Hammad ;
Schneider, Frank ;
Clausen, Sven ;
Blank, Elena ;
Herskind, Carsten ;
Afzal, Muhammad ;
Wenz, Frederik .
RADIATION ONCOLOGY, 2011, 6
[5]   Second cancer after radiotherapy, 1981-2007 [J].
Bartkowiak, Detlef ;
Humble, Nicole ;
Suhr, Peter ;
Hagg, Juliane ;
Mair, Katharina ;
Polivka, Bernd ;
Schneider, Uwe ;
Bottke, Dirk ;
Wiegel, Thomas .
RADIOTHERAPY AND ONCOLOGY, 2012, 105 (01) :122-126
[6]   CANCER IN THE CONTRALATERAL BREAST AFTER RADIOTHERAPY FOR BREAST-CANCER [J].
BOICE, JD ;
HARVEY, EB ;
BLETTNER, M ;
STOVALL, M ;
FLANNERY, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12) :781-785
[7]   FREQUENT CHEST-X-RAY FLUOROSCOPY AND BREAST-CANCER INCIDENCE AMONG TUBERCULOSIS PATIENTS IN MASSACHUSETTS [J].
BOICE, JD ;
PRESTON, D ;
DAVIS, FG ;
MONSON, RR .
RADIATION RESEARCH, 1991, 125 (02) :214-222
[8]   Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy [J].
Donovan, Ellen ;
Bleakley, Natalie ;
Denholm, Erica ;
Evans, Phil ;
Gothard, Lone ;
Hanson, Jane ;
Peckitt, Clare ;
Reise, Stephanie ;
Ross, Gill ;
Sharp, Grace ;
Symonds-Tayler, Richard ;
Tait, Diana ;
Yarnold, John .
RADIOTHERAPY AND ONCOLOGY, 2007, 82 (03) :254-264
[9]   IMRT for breast.: A planning study [J].
Fogliata, A ;
Nicolini, G ;
Alber, M ;
Asell, M ;
Dobler, B ;
El-Haddad, M ;
Hårdemark, B ;
Jelen, U ;
Kania, A ;
Larsson, M ;
Lohr, F ;
Munger, T ;
Negri, E ;
Rodrigues, C ;
Cozzi, L .
RADIOTHERAPY AND ONCOLOGY, 2005, 76 (03) :300-310
[10]   Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG) [J].
Grantzau, Trine ;
Mellemkjaer, Lene ;
Overgaard, Jens .
RADIOTHERAPY AND ONCOLOGY, 2013, 106 (01) :42-49